← Leaderboards
David B. Hackney
University Of Pennsylvania
$4,113,862
Attributed
$6,683,617
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,683,617 · 3
By mechanism
R01$6,021,635 · 2
R56$661,982 · 1
Top collaborators
- Ron N Alkalay7 shared
- Tracy A. Balboni7 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Scott D Halpern$22,081,759
- Wendy G Lichtenthal$6,735,860
- George Demiris$12,229,431
- Barbara S Medoff-Cooper$8,128,036
- Louis J. Soslowsky$25,716,013
Others in their field
Top investigators on “Predictive Marker”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- David Heimbrook · Leidos Biomedical Research, Inc.$87,044,670
- Paul S. Aisen · Cognition Therapeutics, Inc.$61,172,440
- Sumithra Jay Mandrekar · Mayo Clinic Rochester$57,061,518
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Peter B. Gilbert · Fred Hutchinson Cancer Center$53,038,414
Research focus
Predictive MarkerSpinal FracturesMetastatic Neoplasm To The BonePathologicScanningSpinalMalignant NeoplasmsMechanicsNeoplasm MetastasisPalliativeRadiationRadiation TherapySensitivity And SpecificityCostFracture RiskHigh RiskClinical CareClinically SignificantFollow-UpMorbidity - Disease RateNeurologic DeficitPainGuidelinesSpine Bone Structure
Grant awards (12)
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$639,383
R01 · FY2024 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$681,073
R01 · FY2023 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$676,550
R01 · FY2022 · AR
Curating musculoskeletal CT data to enable the development of AI/ML approaches for analysis of clinical CT in patients with metastatic spinal disease$352,266
R01 · FY2022 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$131,892
R01 · FY2021 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$711,487
R01 · FY2020 · AR
Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease$661,982
R56 · FY2019 · AR
MR of post traumatic axonal de- and regeneration$563,796
R01 · FY2005 · NS
MR of post traumatic axonal de- and regeneration$573,998
R01 · FY2004 · NS
MR of post traumatic axonal de- and regeneration$563,793
R01 · FY2003 · NS
MR of post traumatic axonal de- and regeneration$553,884
R01 · FY2002 · NS
MR of post traumatic axonal de- and regeneration$573,513
R01 · FY2001 · NS